Projected health and economic benefits of the use of sirolimus-eluting coronary stents

Advanced Studies in Medicine

Volumn 3, Issue 6 D, 2003, Pages

  Ruffy, Rodolphe ^a,b   Kaden, Raymond J ^b  

^a CardioScript International   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN;

CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; HEALTH CARE COST; HOSPITAL COST; LENGTH OF STAY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; REIMBURSEMENT; RESTENOSIS; REVIEW; TECHNOLOGY;

EID: 0037634697     PISSN: 15303004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med. 1987;316:701-706.
2. Roubin GS, Cannon AD, Agrawal SK, et al. Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation. 1992;85:916-927.
3. Serruys PW, de Jaegere P, Kiemeneij F, et al, for The Benestent Study Group. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994; 331:489-495.
4. Fischman DL, Leon MB, Baim D, et al, for the STRESS Trial Investigators. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994; 331:496-501.
5. Serruys PW, de Bruyne B, Carlier S, et al. Randomized comparison of primary stenting and provisional balloon angioplasty guided by flow velocity measurement. Circulation. 2000;102:2930-2937.
6. Serruys PW, Unger F, Sousa JE, et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. Arterial Revascularization Therapies Study. N Engl J Med. 2001;344:1117-1124.
7. Dussaillant GR, Mintz GS, Pichard AD, et al. Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis. J Am Coll Cardiol. 1995;26:720-724.
8. Hoffman R, Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study. Circulation. 1996;94:1247-1254.
9. "Hospital Readmission Following Coronary Artery Bypass Graft Surgery" October 2001 report by the Pennsylvania Health Care Cost Containment Council.
10. de Feyter PJ, Vos J, Rensing BJ. Anti-restenosis trials. Curr Intervent Cardiol Rep. 2000;2:326-331.
11. Sousa JE, Costa MA, Abizaid A, et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries, a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation. 2001;103:192-195.
12. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002; 346:1773-1780.
13. Ho KK, Senerchia C, Rodriguez O, et al. Predictors of angiographic restenosis after stenting: pooled analysis of 1197 patients with protocol-mandated angiographic follow-up from 5 randomized stent trials [abstract]. Circulation. 1998;98(suppl 1):362.